Tag results:
AMPK
Hepatic Cell News
Clitorin Ameliorates Western Diet-Induced Hepatic Steatosis by Regulating Lipogenesis and Fatty Acid Oxidation In Vivo and In Vitro
[Scientific Reports] Researchers investigated the inhibitory effects and underlying governing mechanism of clitorin in a western diet-induced hepatic steatosis mouse model, and in oleic acid-stimulated HepG2 cells.
Hepatic Cell News
Sestrin2 Protects against Cholestatic Liver Injury by Inhibiting Endoplasmic Reticulum Stress and NLRP3 Inflammasome-Mediated Pyroptosis
[Experimental and Molecular Medicine] Researchers investigated the role of hepatic Sestrin2 in cholestatic liver injury and its underlying mechanisms using in vivo and in vitro approaches.
Endothelial Cell News
Redox Signaling by Glutathione Peroxidase 2 Links Vascular Modulation to Metabolic Plasticity of Breast Cancer
[Proceedings of the National Academy of Sciences of the United States of America] Glutathione peroxidase 2 (GPx2) loss stimulated malignant progression due to reactive oxygen species/hypoxia inducible factor-α (HIF1α)/VEGFA signaling, causing poor perfusion and hypoxia, which were reversed by GPx2 reexpression or HIF1α inhibition.
Intestinal Cell News
lncRNA TUG1 Protects Intestinal Epithelial Cells from Damage Induced by High Glucose and High Fat via AMPK/SIRT1
[Molecular Medicine Reports] Protein expression was detected by western blotting. Cell Counting Kit‑8 assays were performed to analyze cell viability, and flow cytometry and a TUNEL assay was performed to evaluate cell apoptosis.
Hepatic Cell News
Resveratrol Induces the Fasting State and Alters Circadian Metabolism in Hepatocytes
[Plant Foods For Human Nutrition] Investigators studied the metabolic effect of resveratrol around the circadian clock in order to determine more accurately the hepatic signaling pathways involved. AML-12 hepatocytes were treated with resveratrol and clock and metabolic markers were measured around the clock.
Dermal Cell News
Tofacitinib and Metformin Reduce the Dermal Thickness and Fibrosis in Mouse Model of Systemic Sclerosis
[Scientific Reports] Researchers investigated the therapeutic efficacy of tofacitinib and metformin on IL-17 and transforming growth factor beta cytokines, skin fibrosis and inflammation in mouse model of systemic sclerosis.